Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Anon Srikiatkhachorn. (2020) What translatable knowledge from dengue vaccine design can we pass onto future anti-parasitic vaccine development?. Expert Opinion on Drug Discovery 15:4, pages 391-395.
Read now
Read now
Annelies Wilder-Smith & In-Kyu Yoon. (2016) Edging closer towards the goal of a dengue vaccine. Expert Review of Vaccines 15:4, pages 433-435.
Read now
Read now
Articles from other publishers (18)
Charu Aggarwal, Viswanathan Ramasamy, Amit Garg, Rahul Shukla & Navin Khanna. (2023) Cellular T-cell immune response profiling by tetravalent dengue subunit vaccine (DSV4) candidate in mice. Frontiers in Immunology 14.
Crossref
Crossref
Stanley A. Plotkin. (2023) Recent updates on correlates of vaccine-induced protection. Frontiers in Immunology 13.
Crossref
Crossref
Pinyi Lu, Dylan J. Guerin, Shu Lin, Sidhartha Chaudhury, Margaret E. Ackerman, Diane L. Bolton & Anders Wallqvist. (2021) Immunoprofiling Correlates of Protection Against SHIV Infection in Adjuvanted HIV-1 Pox-Protein Vaccinated Rhesus Macaques. Frontiers in Immunology 12.
Crossref
Crossref
Flor M. Munoz, Jakob P. Cramer, Cornelia L. Dekker, Matthew Z. Dudley, Barney S. Graham, Marc Gurwith, Barbara Law, Stanley Perlman, Fernando P. Polack, Jonathan M. Spergel, Eva Van Braeckel, Brian J. Ward, Arnaud M. Didierlaurent & Paul Henri Lambert. (2021) Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 39:22, pages 3053-3066.
Crossref
Crossref
Laszlo Szekely, Bela Bozoky, Matyas Bendek, Masih Ostad, Pablo Lavignasse, Lars Haag, Jieyu Wu, Xu Jing, Soham Gupta, Elisa Saccon, Anders Sönnerborg, Yihai Cao, Mikael Björnstedt & Attila Szakos. (2021) Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of COVID-19 death. Heliyon 7:5, pages e07134.
Crossref
Crossref
Pengfei Jin, Jingxin Li, Hongxing Pan, Yanfei Wu & Fengcai Zhu. (2021) Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Marianna Redoni, Sophie Yacoub, Laura Rivino, Daniele Roberto Giacobbe, Roberto Luzzati & Stefano Di Bella. (2020) Dengue: Status of current and under‐development vaccines. Reviews in Medical Virology 30:4.
Crossref
Crossref
Joshua Blight, Eduardo Alves & Arturo Reyes-Sandoval. (2019) Considering Genomic and Immunological Correlates of Protection for a Dengue Intervention. Vaccines 7:4, pages 203.
Crossref
Crossref
Adrienne Guignard, François Haguinet, Stéphanie Wéry & Phirangkul Kerdpanich. (2019) Prevalence and Persistence of Maternal Dengue Neutralizing Antibodies in Infants From Central and Southern Thailand: A Retrospective Cohort Study. Asia Pacific Journal of Public Health 31:4, pages 288-295.
Crossref
Crossref
Marcos A. EspinalJon K. AndrusBarbara JaureguiStephen Hull WatermanDavid Michael MorensJose Ignacio SantosOlaf HorstickLorraine Ayana FrancisDaniel Olson. (2019)
Emerging and Reemerging
Aedes
-Transmitted Arbovirus Infections in the Region of the Americas: Implications for Health Policy
. American Journal of Public Health 109:3, pages 387-392.
Crossref
Crossref
Sarah L. Keasey, Jessica L. Smith, Stefan Fernandez, Anna P. Durbin, Bryan M. Zhao & Robert G. Ulrich. (2018) Impact of Dengue Virus Serotype 2 Strain Diversity on Serological Immune Responses to Dengue. ACS Infectious Diseases 4:12, pages 1705-1717.
Crossref
Crossref
Ravi Kant Rajpoot, Rahul Shukla, Upasana Arora, Sathyamangalam Swaminathan & Navin Khanna. (2018) Dengue envelope-based ‘four-in-one’ virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice. Scientific Reports 8:1.
Crossref
Crossref
Diogo M. Magnani, Cassia G. T. Silveira, Michael J. Ricciardi, Lucas Gonzalez-Nieto, Núria Pedreño-Lopez, Varian K. Bailey, Martin J. Gutman, Helen S. Maxwell, Aline Domingues, Priscilla R. Costa, Lilian Ferrari, Raphaella Goulart, Mauricio A. Martins, José M. Martinez-Navio, Sebastian P. Fuchs, Jorge Kalil, Maria do Carmo Timenetsky, Jens Wrammert, Stephen S. Whitehead, Dennis R. Burton, Ronald C. Desrosiers, Esper G. Kallas & David I. Watkins. (2017) Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine. Journal of Virology 91:22.
Crossref
Crossref
Noemia S. Lima, Morgane Rolland, Kayvon Modjarrad & Lydie Trautmann. (2017) T Cell Immunity and Zika Virus Vaccine Development. Trends in Immunology 38:8, pages 594-605.
Crossref
Crossref
Alba Grifoni, Michael Angelo, John Sidney, Sinu Paul, Bjoern Peters, Aruna D. de Silva, Elizabeth Phillips, Simon Mallal, Sean A. Diehl, Jason Botten, Jonathan Boyson, Beth D. Kirkpatrick, Stephen S. Whitehead, Anna P. Durbin, Alessandro Sette & Daniela Weiskopf. (2017) Patterns of Cellular Immunity Associated with Experimental Infection with rDEN2Δ30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain. Journal of Virology 91:8.
Crossref
Crossref
Michael A. Angelo, Alba Grifoni, Patrick H. O'Rourke, John Sidney, Sinu Paul, Bjoern Peters, Aruna D. de Silva, Elizabeth Phillips, Simon Mallal, Sean A. Diehl, Beth D. Kirkpatrick, Stephen S. Whitehead, Anna P. Durbin, Alessandro Sette & Daniela Weiskopf. (2017)
Human CD4
+
T Cell Responses to an Attenuated Tetravalent Dengue Vaccine Parallel Those Induced by Natural Infection in Magnitude, HLA Restriction, and Antigen Specificity
. Journal of Virology 91:5.
Crossref
Crossref
Gokul Swaminathan, Elizabeth A. Thoryk, Kara S. Cox, Jeffrey S. Smith, Jayanthi J. Wolf, Marian E. Gindy, Danilo R. Casimiro & Andrew J. Bett. (2016) A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates. Scientific Reports 6:1.
Crossref
Crossref
Beth D. KirkpatrickStephen S. WhiteheadKristen K. PierceCecilia M. TiberyPalmtama L. GrierNoreen A. HynesCatherine J. LarssonBeulah P. SabundayoKawsar R. TalaatAnna JaniakMarya P. CarmolliCatherine J. LukeSean A. DiehlAnna P. Durbin. (2016) The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model. Science Translational Medicine 8:330.
Crossref
Crossref